| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |